BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, Vanlandschoot P, Desombere I. Prevention of hepatitis B infections: vaccination and its limitations. Acta Clin Belg. 2001;56:209-219. [PMID: 11603250 DOI: 10.1179/acb.2001.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Vanlandschoot P, Van Houtte F, Hoek F, Nieuwland R, Leroux-roels G. Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity. J Med Virol 2003;70:513-9. [DOI: 10.1002/jmv.10425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
2 Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. J Clin Transl Hepatol 2019;7:165-71. [PMID: 31293917 DOI: 10.14218/JCTH.2018.00037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Shokrgozar MA, Sam MR, Amirkhani A, Shokri F. Frequency Analysis of HBsAg-specific B Lymphocytes in High-responder Individuals to Recombinant Hepatitis B Vaccine: Comparison of LDA and ELISPOT Assays. Scand J Immunol 2006;64:536-43. [DOI: 10.1111/j.1365-3083.2006.01838.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
4 Noordeen F, Theneshkar S, Arunasalam S. Protective immunity in a sample of healthy adults following vaccination with a more cost effective recombinant HBsAg vaccine. Journal of Clinical Virology Plus 2022;2:100056. [DOI: 10.1016/j.jcvp.2021.100056] [Reference Citation Analysis]
5 Das K, Gupta RK, Kumar V, Kar P. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders. World J Gastroenterol 2003; 9(5): 1132-1134 [PMID: 12717874 DOI: 10.3748/wjg.v9.i5.1132] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
6 Nakao K, Hamasaki K, Wakihama N, Maeda M, Ohtsubo N, Sagiike T, Ichikawa T, Ishikawa H, Eguchi K, Ishii N. Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus. Vaccine 2003;21:3789-94. [DOI: 10.1016/s0264-410x(03)00313-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ninyio NN, Ho KL, Ong HK, Yong CY, Chee HY, Hamid M, Tan WS. Immunological Analysis of the Hepatitis B Virus "a" Determinant Displayed on Chimeric Virus-Like Particles of Macrobrachium rosenbergii Nodavirus Capsid Protein Produced in Sf9 Cells. Vaccines (Basel) 2020;8:E275. [PMID: 32512923 DOI: 10.3390/vaccines8020275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, Gomez-gutierrez J, Gavilanes F, Leroux-roels G. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. Journal of General Virology 2002;83:2279-89. [DOI: 10.1099/0022-1317-83-9-2279] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
9 Ye X, Zhou M, He Y, Wan Y, Bai W, Tao S, Ren Y, Zhang X, Xu J, Liu J, Zhang J, Hu K, Xie Y. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide. Sci Rep 2016;6:29391. [PMID: 27384014 DOI: 10.1038/srep29391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Verstraeten T, Fletcher MA, Suaya JA, Jackson S, Hall-Murray CK, Scott DA, Schmöle-Thoma B, Isturiz RE, Gessner BD. Diabetes mellitus as a vaccine-effect modifier: a review. Expert Rev Vaccines 2020;19:445-53. [PMID: 32516066 DOI: 10.1080/14760584.2020.1760098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]